Affiliation:
1. Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H3G 2M1, Canada
2. Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada
3. Division of Dermatology, McGill University Health Centre, Montréal, QC H4A 3J1, Canada
Abstract
Incidence rates of melanoma and keratinocyte skin cancers have been on the rise globally in recent decades. While there has been a select focus on personal sun protection awareness, to our knowledge, there is a paucity of legislation in place to help support citizens’ efforts to protect themselves from the harmful effects of ultraviolet radiation (UVR). Given this, we conducted a comprehensive review of legislation and guidelines pertaining to a variety of sun protection-related topics in countries of the Group of Seven (G7), Australia and New Zealand. Australia was the only country to have banned tanning beds for individuals of all ages, while other select countries have instituted bans for minors. In workplace policy, there is very little recognition of the danger of occupational UVR exposure in outdoor workers, and thus very few protective measures are in place. With regard to sports and recreation, certain dermatological/professional associations have put forward recommendations, but no legislation was brought forward by government bodies outside of Australia and New Zealand. With regard to youth, while there are various guidelines and frameworks in place across several countries, adherence remains difficult in the absence of concrete legislation and standardization of procedures. Finally, only Australia and a few select jurisdictions in the United States have implemented sales tax exemptions for sunscreen products. In light of our findings, we have made several recommendations, which we anticipate will help reduce the rates of melanoma and keratinocyte cancers in years to come. However, minimizing UVR exposure is not without risk, and we, therefore, suggest the promotion of vitamin D supplementation in conjunction with sun protective practices to limit potential harm.
Funder
Canadian Cancer Society
Canadian Institutes of Health Research
CIHR Project Scheme
CIHR Catalyst
Cancer Research Society (CRS)-CIHR Partnership
Fonds de la recherche du Québec–Santé
Reference141 articles.
1. Population-Based Study Detailing Cutaneous Melanoma Incidence and Mortality Trends in Canada;Conte;Front. Med.,2022
2. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study;Ghazawi;J. Am. Acad. Dermatol.,2019
3. Cancer statistics, 2023;Siegel;CA Cancer J. Clin.,2023
4. Melanoma Epidemiology and Early Detection in Europe: Diversity and Disparities;Forsea;Dermatol. Pract. Concept.,2020
5. Saginala, K., Barsouk, A., Aluru, J.S., Rawla, P., and Barsouk, A. (2021). Epidemiology of Melanoma. Med. Sci., 9.